title: Hypoglycaemia, analogue insulins; prescribing cost or quality of life?
authors.forename: G A
authors.initials: GA
authors.lastname: Hitman
mesh_terms: D001766:Blindness / Q000191:economics / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D003863:Depression / Q000191:economics / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000191:economics; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000191:economics; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics / Q000627:therapeutic use*; D007328:Insulin / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D008297:Male; D011788:Quality of Life
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin